Viewing Study NCT02615444



Ignite Creation Date: 2024-05-06 @ 7:51 AM
Last Modification Date: 2024-10-26 @ 11:53 AM
Study NCT ID: NCT02615444
Status: UNKNOWN
Last Update Posted: 2016-09-27
First Post: 2015-11-05

Brief Title: The Effects of Beta-glucan Enriched Oatcake Consumption on Metabolic Disease Risk Factors
Sponsor: Queen Margaret University
Organization: Queen Margaret University

Study Overview

Official Title: An Investigation of the Effects of Consuming Oatcakes Containing 4g of Oat Beta-glucan on Physiological Parameters in Individuals at Risk of Developing Metabolic Syndrome
Status: UNKNOWN
Status Verified Date: 2016-09
Last Known Status: ENROLLING_BY_INVITATION
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine whether daily consumption of soluble fibre oat beta glucan 4g for six weeks will have any impact on overweightobese individuals in terms of risk factors used to define metabolic disease
Detailed Description: The purpose of this study is to determine whether daily consumption oat beta glucan 4g for six weeks will have any impact on overweightobese individuals in terms of risk factors used to define metabolic disease

Oat beta-glucan has been incorporated into a novel oatcake product manufactured by Nairns Oatcakes Ltd Consumption of the oatcake products will deliver enough oat-beta glucan to the diet to meet European Food Safety Authority health claims for lowering blood cholesterol and reducing post-prandial glycaemic responses

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None